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ABSTRACT This paper intends to present a Web-based application to collect and manage clinical data and
clinical trials together in a unique tool. I-maculaweb is a user-friendly Web-application designed to manage,
share, and analyze clinical data from patients affected by degenerative and vascular diseases of the macula.
The unique and innovative scientific and technological elements of this project are the integration with
individual and population data, relevant for degenerative and vascular diseases of the macula. Clinical records
can also be extracted for statistical purposes and used for clinical decision support systems. I-maculaweb is
based on an existing multilevel and multiscale data management model, which includes general principles
that are suitable for several different clinical domains. The database structure has been specifically built
to respect laterality, a key aspect in ophthalmology. Users can add and manage patient records, follow-
up visits, treatment, diagnoses, and clinical history. There are two different modalities to extract records:
one for the patient’s own center, in which personal details are shown and the other for statistical purposes,
where all center’s anonymized data are visible. The Web-platform allows effective management, sharing,
and reuse of information within primary care and clinical research. Clear and precise clinical data will
improve understanding of real-life management of degenerative and vascular diseases of the macula as well as
increasing precise epidemiologic and statistical data. Furthermore, this Web-based application can be easily
employed as an electronic clinical research file in clinical studies.
INDEX TERMS Macula diseases, Web based clinical data collection for reuse, multi-level and multi-scale
data management model.
I. INTRODUCTION
Electronic Health Records (EHR) play an important role
in the improvement of data collection and healthcare
efficiency [1]. Some papers on Evidence-Based Medicine
recognize the value of a data set to guide clinical decision-
making [1], [2].
EHRs offer significant advantages to patients as well.
By facilitating storage, retrieval and communication between
different healthcare providers, patients do not need to look
after their own information and possible mistakes can be
avoided when receiving care from different physicians [3].
However, due to the large amounts of heterogeneous
information stored (i.e. laboratory values, text-based
documents, demographics, and medications), EHRs can be
difficult to search and relevant patient information hard to
retrieve [4]. Finding a solution to overcome this issue is
complex, particularly since it is difficult to obtain the right
balance between easy access and the amount of information
stored [4].
Degenerative and vascular diseases of the retina are
the main causes of legal blindness in industrialized coun-
tries (Europe, US, Asia). The incidence in the population
has increased steadily over the years as a consequence of
ageing and the increased prevalence of systemic diseases
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(e.g. diabetes and hypertension). For example: an estimated
20 – 25 million people worldwide currently have Age-related
Macular Degeneration (AMD) and this number is expected to
increase as a result of aging of the population and increased
life expectancy [5]. Diabetes mellitus is the most com-
mon endocrine disease in developed countries, with preva-
lence estimates ranging between 2% to 5% of the world’s
population [6]. Diabetic Macular Edema (DME) is another
important cause of severe deterioration of visual acuity. It has
been estimated that in the US in 2010, about 740.000 people
had DME [7].
The recent introduction of new treatment modalities,
i.e. anti-vegf drugs, has significantly decreased the rate of
legal blindness due to macular pathologies [8]. However due
to the transient effect of these new drugs, patients need to be
monitored on a monthly-basis and treated as needed through
complex longitudinal follow-up programs. It has been pre-
viously reported that the level of benefit of such treatment
seen in randomized trials has not been achieved using either
a monthly-based follow-up or a treat-and-extend strategy [9].
Within this complicated scenario, systems and software appli-
cations are needed to correctly store, manage, and analyze
the large amount of heterogeneous data. Moreover, routinely
collected data about treatments could provide new evidence
about the efficiency of clinical trial results and real-life
clinical outcomes. Such systems and software applications
should: allow easy access to complete patient information
to help the ophthalmologist in the decision-making process;
implement a user-friendly interface, which intuitively allows
performing complex tasks such as data extraction and statis-
tical analysis. Furthermore, these applications should involve
end-users in all phases of the software life cycle; permit data
sharing and integration between different levels of medical
care as well as national and international institutions, to
stimulate collaborations and favor public health policies on
macular diseases.
The benefits of the integration between different levels
of medical care and clinical research have already been
shown [10] andmanyworkgroups are focusing their strengths
on achieving this objective [11]. However, vendors of elec-
tronic medical/health record systems are so far, still not work-
ing in the same direction. Consequently, a wide integration
of administration and routine care information systems with
those used for clinical research is not yet possible.
Bibliographic research reveals that the more frequently
used EHR tools in ophthalmology do not offer the possibility
for a fine-tuned interface and for smart data extraction in
external statistical studies [12]–[15].
Therefore, particularly in the academic community where
financial resources are lacking, physicians have to adopt
craft-made or open source solutions (eg, OpenClinica [16],
OpenCDMS [17], REDCap [18]) to manage data in clin-
ical trials. Furthermore, to fulfil clinical trial protocol
requirements, repetitive and time consuming manual data
copy operations are generated, with increased possibilities
of introducing errors [19]–[21]. In clinical trials the use of
longitudinal follow-up is increasing [22], with new and more
advanced statistical methodologies needed.
Furthermore, in ophthalmology, the inclusion of paired-eye
data in prospective studies complicates multilevel structuring
of data and its analysis; this complexity should be identified
and considered before the study [22].
One of the main issues in implementing an EHR system in
ophthalmology is the representation of medical concepts [3].
Often, customised solutions are used that refer to inconsis-
tent terminologies, which make it difficult to compare data
coming from different sites and for physicians to interpret
stored data [3]. Therefore, the use of standard terminologies
to describe the different events is an essential component of
an efficient and coherent system. The International Classifi-
cation of Diseases 9th Revision [23] and Logical Observation
Identifiers, Names and Codes [24], which provides universal
names and codes for laboratory and clinical observations, can
be used to achieve this goal [3].
Concerning the means of delivering the system, web-based
solutions are increasingly used [25], [26]. In fact, once
in possession of the view rights and credentials, it allows
quick access to information from anywhere only requiring
an internet connection and a computer; moreover, it is not
necessary to install any software only a web browser to go
online [10], [27].
This paper intends to present I-maculaweb, a web-based
platform to collect and manage data in a routine clinical prac-
tice as well as integrating it with data from clinical research
in an Ophthalmology domain. In particular, it focuses on
patients affected by degenerative and vascular diseases of
the macula. The platform, via state-of-the-art technological
methods, brings a novel perspective to ophthalmology by
combining individual patients and population data relevant
for degenerative and vascular diseases of the macula. Fur-
thermore, stored data can be extracted for statistical purposes
and used for clinical decision support systems. The platform
is available for different simultaneous multicenter Clinical
Trials. The proposed system takes into account personal
medical data accumulated over time in order to develop a
Clinical Decision Support System. Moreover, the inclusion
of standardization procedures offers a stable quality of data
over time.
II. CLINICAL DATA
Most of the clinical data, collected during ophthalmological
visits, comprised phenotypic characterization of the patients
(signs and symptoms), including records of in vivo images,
or data concerning administration of therapeutics and nutri-
tion/exposure to environmental factors. Data were also linked
to computer models of personalized algorithms for drug
administration, physiology, functional disorders and other
diseases.
Numerical values are used to quantify visual acuity as
well as the thickness of the retina. Early Treatment Diabetic
Retinopathy Study (ETDRS) charts have been employed
in many clinical trials and is accepted worldwide as the
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gold Standard for accurate and standardized methodology
to measure visual acuity [28]. Optical Coherence Tomog-
raphy (OCT) is used to obtain detailed B-scan images and
to quantify the thickness of the central part of the retina
(macula). OCT is considered a mandatory step in the evalu-
ation and follow-up of degenerative and vascular diseases of
the macula. In addition to OCT, ophthalmoscopy and retinal
angiography were also employed to obtain images of the
retina, so that objective values could be observed and changes
over time, evaluated.
FIGURE 1. Architecture solution.
III. METHODS
A. ARCHITECTURE SOLUTION
Many aspects were considered for the choice of the archi-
tecture solution. After continuous interaction with the users
and considering the positive features described above [10], a
web basedDatabase interaction systemwas used. In ‘‘Fig. 1’’,
the architecture solution, the web-application relies on a SQL
database where data are stored and retrieved through stan-
dard terminologies and users (i.e. ophthalmologist) can enter,
access and retrieve information on the web as well as saving
reports in Microsoft Excel and PDF formats. The figure also
shows the way in which the proposed solution was integrated
with the Hospital Information System (HIS), in particular
with the Electronic Health Record (EHR) and the Patient
Administration System (PAS). Some authors were involved
in the design and implementation of a standardized infrastruc-
ture that was able to completely support interoperability for
the HIS of the care facility involved in the proposed solution.
The standardized infrastructure was based on the Service
Oriented Architecture (SOA) paradigm to support technical
interoperability and it exchanged HL7 Version 3 (v3) Clinical
Document Architecture (CDA) Release 2 (R2) [29] objects
combined with standardized vocabularies to ensure semantic
interoperability. Finally, its web service interfaces were com-
pliant to Healthcare Services Specification Project (HSSP)
[30] standards (Retrieve, Locate andUpdate Services (RLUS)
Release 1 [31], [32] and Identification and Cross-Reference
Service (IXS) Release 1 [33], [34]) to provide process inter-
operability [35]–[37]. This infrastructure provided access to
the content of the EHR and PAS of the same hospital for
other similar research purposes [38]. As shown in ‘‘Fig. 1’’,
the proposed solution was connected with the HIS, adopting
the same strategy reported by Gazzarata et al. [38].
In detail, the web application described in this manuscript
represents a client agent of the EHR web service that adopts
the put() functionality of RLUS standard to feed the EHR
with a clinical document [35].
In this project, we used a Microsoft SQL Server 2014 as
the Database Management System [39] and a .NET frame-
work [40] to develop the web application respectively [40].
B. MULTI-LEVEL AND MULTI-SCALE MODEL
The I-maculaweb database is based on an existing multi-
level and multi-scale data management model based on some
general principles, which are suitable for several different
clinical domains. Previous implementation of such a tem-
plate originated a specific tool for data reuse in Infective
Diseases [19].
FIGURE 2. Example of the multi-level structure.
‘‘Fig. 2’’ shows the conceptual framework developed.
In detail, it is structured on a three-level hierarchical struc-
ture: Clinical Events, Categories, Parameters (with Unit of
measure). Results are appropriately contextualized for the
patient and for the time of measurement. For example,
information concerning the ‘‘Letters score’’ and ‘‘Axis’’ are
parameters that are grouped into the ‘‘Visual acuity’’ Cate-
gory that belongs to the ‘‘Eye examination’’ Event.
Clinical results, obtained during the visit, are automatically
saved in several tables according to the type of parameter and
format to save.
Centers often utilize different instruments such as OCT,
so numeric parameters, in particular the integer and
float value may have different characteristics, like normal
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ranges or units. These differences are central to the data
extraction phase, therefore relevant information is specif-
ically recorded for each center (‘‘Unit_Conversion’’ and
‘‘Conversion_Coefficients’’ tables in the database). In detail,
all possible conversion coefficients between different units
are stored. Finally, once converted to the same unit, data are
harmonized using the z-score methodology, which allows the
comparison of data collected with different normal ranges.
Patients and operators are both saved in the table ‘‘Person’’
where encrypted name, date of birth, address, telephone
number and other mainly general demographic information
are saved. The patient’s tax code is generated automatically,
using the demographic information, and then compared with
the actual code stated by the patient, in order to ensure reliable
patient identification.
The operator role and affiliate center are stored in a sepa-
rate table. In this way, a physician can also assume different
roles in different hospitals. Access to the database is strictly
limited to authorized physicians with credentials checked for
their security level and with a strict change policy. Further-
more, each user can be authorized, with different levels of per-
mission, to access various studies; this information is stored
in ‘‘Operator_Studies’’. All actions are recorded and linked to
the specific operator, through the concept of sessions, which
include the date and time of the user login.
C. LATERALITY
The database structure was designed specifically to respect
laterality, a key aspect in ophthalmology. As the template
used to develop this database was mainly focused on general
clinical concepts, it does not consider the concept of laterality.
For this reason, a new table was added to identify the eye
responsible for a specific parameter. In this way, each result
is associated with the correct eye. Laterality was also added
to the table of ‘‘Patients in Studies’’ because, in many cases,
only one or both eyes could be enrolled in the study.
D. STANDARD INTERACTIONS
In order to manage semantics, LOINC and ICD9were used in
this application, which translated the local vocabularies into
sharable information. In particular, in the table ‘‘Parameters’’
the associated LOINC codes are specified and diagnosis can
be chosen from a table where the corresponding IDC9 codes
are saved.
As previously mentioned, all data recorded in a clinical
event, ‘‘eye examination’’, were mapped within a CDA R2
document to feed the EHR. In order to constrain the
CDA R2 specification for this specific use case, the Italian
CDA R2 Implementation Guide (CDA R2 IG) for Discharge
Summarization Note [41] was adopted.
E. MODULARITY
The modular nature of both the database and web interface
could allow a moderately easy definition of similar approach
in other medical fields. The key aspect of the system is
a relational database which, by using high data structuring
through a meta description approach, permits archiving of
various types of clinical information in multiple formats.
The modular design of the database allows the quick addi-
tion of new parameters without any required modification to
the database structure, even if the strong relational structure of
the database is maintained, ensuring a data set of high quality.
In particular, this aspect is essential within the macular dis-
ease context because, management and treatment criteria are
constantly evolving; therefore, the inclusion of new criteria is
often necessary.
The database is managed through a web-platform, which
dynamically builds the required web pages [20]. One relevant
characteristic is that once the data has been collected into the
database the first time, it is then available, without any further
copy operations, during routine clinical care and for clinical
studies according to specific research purposes.
All web page contents, in terms of components through
ASP.NET’s ASCX controls [42], [43], were dynamically
loaded by using the archived information in the database.
The web application was built starting from basic bricks,
which give access to specific portions of the database (even
at the level of a single parameter / categories). These portions
are frequently present in different pages whose content and
order are defined according to the specific study.
Both the modularity and multi-level features of the present
tool makes the creation of new studies, which can be consid-
ered the fifth and most external level of the system, very easy.
In fact, all features present can be imported into a study with-
out data replication and registered people can be indicated by
automatic routines starting from a formal description of the
study protocol. To enhance the potentiality of these modu-
lar features, a maintenance layer was developed to provide
administrators with quick access and enable modification to
all structural aspects of the platform as well as rapid addition
of new clinical features.
F. SECURITY
Confidentiality is a main factor in the platform. To respect
patients’ privacy, all sensitive data are stored using a hash
cryptography algorithm during the registration process and a
strict viewing rights policy. Although, each patient is enrolled
in the database by a physician operating in the center where
he/she receives healthcare services, patients’ anonymized
data are accessible by other center users if needed, only in
aggregate format. As the whole system is based on web,
Hypertext Transfer Protocol Secure [44], a protocol for safe
communication, was employed to encrypt data flow between
the client and server. During the login process, the connection
switches from an unprotected connection to a safe one in
order to safely exchange credentials and all clinical data
during each session. Crucial memory segment isolation was
used to assure transaction independency, in order to avoid
interaction problems in multiple user access, mainly dur-
ing simultaneously access to the database. A medium level
isolation approach was chosen, allowing multiple simulta-
neous connections to databases from different procedures
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but, within the same procedure, no simultaneous connections
were allowed.
G. USABILITY
The development of the interface was performed using the
AGILE [45] methodology with strict interaction with end
users in order to get indications to obtain an extremely user-
friendly tool that would cover all their needs in this field. This
is the main reason for its good acceptance and integration into
a routine workflow.
Since one of the main objectives was to allow physicians
to extract data for research and epidemiological purposes,
a specific extraction tool was developed. Such instruments
permit physicians to access normalized and comparable infor-
mation according to their criteria and to extract these data in a
portable format. Moreover, the search rationale can be saved
for future needs and integration with the same modularity
philosophy present in the whole tool.
FIGURE 3. Web interface sections and functionality.
IV. RESULTS
The Web Platform architecture (shown in Fig.3) is struc-
tured in two different sections: Clinical section and Research
section. By using the Clinical section, with a user friendly and
intuitive interface, physicians are able to record, modify and
view patients’ results. On the other hand, the research section
is used to extract and export information according to the
requirements. Referring to the first activities, the process is
structured in a few passages and almost all web page contents
are dynamically loaded. Physicians are able to access the
Centre’s Patients list, from which a patient can be selected
to display further details. The Clinical section main menu
shows patient details and it is organized as follow: unique
identification number of the patient, last and first name, date
of birth, gender, date of the last visit, center Id, and three
buttons linked to demographic data, clinical chart and delete
function pages. The web page ‘‘Patient’s Clinical chart home-
page’’ shows a summary of specified patient activity (visits,
diagnoses, Intravitreal/laser/surgery treatments, clinical stud-
ies) that the system automatically loads from the list of the
Clinical Events associated with the selected patient. As soon
as there are more than two visits, ETDRS score letters and
mean Central Macular Thickness (CMT) are plotted onto two
separate graphs in the clinical homepage.
If a patient participates in a specific study, the relative
information is highlighted in an ad hoc panel. For exam-
ple, indications for Intravitreal treatments, according to the
‘‘Two Eyes’’ study, are inserted in a red rectangle. If the
patient is not yet enrolled in a study, but he/she has the feature
to be inserted, an study-specific alert button is visible on the
page.
After choosing the particular Clinical Event, the platform
shows the related list of available Categories. After selecting a
specific Category, physicians can access a Parameter list and
record or view results; the web page is dynamically loaded in
relation to the Parameters format, Centre’s units and ranges.
Lastly, the physician can save the results in a report that the
web application encapsulates within a CDAR2 document and
sends to the hospital EHR calling the put() capability of the
RLUS interface.
FIGURE 4. ETRDS chart shows the trend of visual acuity during the
follow-up.
In order to improve the visualization and contextualiza-
tion of the data, each graph can be enlarged to full-screen
size. In this case, temporary sequences of ETDRS score
letters and CMT values are automatically put in relation
to the patient’s recorded therapies. Therapies are identified
(with simple color and form differentiation) according to the
method and/or drug used (‘‘Fig. 4’’). The ‘‘Visit’’ menu is
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FIGURE 5. OCT results are automatically imported in the application.
divided in four sections: visus and symptoms, anterior and
posterior segment, topical therapies ongoing and report. The
main characteristic of the visus and symptoms section is the
automatic calculation of the ETDRS score letter and Snellen
equivalent. To simplify this operation an electronic image of
the ETDRS chart pops out. The operator only needs to digit
the number of letters correctly read at each line and the sys-
tem automatically calculates the ETDRS score and Snellen
equivalent [46]. In the posterior and anterior segment section,
there are four different menus regarding OCT, ophthalmo-
scopic, angiographic and anterior segment signs. In some
cases, such as subretinal fluid or cystoid macular edema, it is
possible to compare the signs with the same signs recorded
at the previous visit, specifying if it has increased, decreased,
disappeared or remained unchanged. As well as the ETDRS
letter score, it is possible to digit the thickness values for the
nine ETDRS thickness field maps available in every OCT
machine and one of the main points to improve in the system
is the automation of data input from clinical instruments to the
database. An application connected to a web service allows
the export of OCT results to the web application, in this
way data will be automatically stored in the database. The
system will automatically calculate the mean value of the
CMT (‘‘Fig. 5’’). Using the same application, direct recording
of patient’s demographics will also be possible.
The treatment menu is divided in injection, laser and surgi-
cal treatments. In the injection treatment section, there is a list
of Intravitreal drugs that can be selected for each eye with the
corresponding injection data. In the laser treatment section,
there is the possibility to select the available retinal laser
treatments, panretinal or scatter photocoagulation, grid/focal
laser, micropulse or subthreshold laser and photodynamic
therapy. It is also possible to save and print a pdf document
as a visit report containing all relevant information collected
during the examination as well as free text comments added
by the physicians.
I-maculaweb has been in use at the Medical Retinal Cen-
ter of the Clinical Ophthalmology, San Martino Hospital in
Genoa, Italy, for about 2 years. In January 2015, the demo-
graphic and clinical information of 1105 patients, affected
by degenerative and vascular disease of the retina, were
entered and managed by I-maculaweb for a total of 3706
visits. The most frequent diagnoses were: AMD (490 cases),
Diabetic Retinopathy (231 cases) and Central Serous Chori-
oretinopathy (155 cases). Furthermore, data related to 13
other diagnoses are present in the database. When needed
other diagnostic sub-classifications are memorized. In the
database, 1582 injective therapies and 257 laser therapies are
also recorded. Some normal macula cases (199) were also
inserted for statistical comparisons.
In addition, I-maculaweb was further implemented with
automatic algorithms to assist ophthalmologists in the
decision-making process related to starting treatment or
re-treatment. These algorithms were developed in order to
help physicians to follow, the Diabetic Retinopathy Clin-
ical Research Network retreatment guidelines [22] and
other international protocols, often expressed in an informal
graphic design. Specifically, using patient diagnoses, visual
acuity, CMT, and follow-up data, the system displayed a hint
to start or stop treatment.
The platform can also be used as an electronic Clinical
Research File, which is now mandatory in clinical studies.
In April 2014, a 12-month prospective, multicenter,
open-label, single arm interventional study (protocol
CRFB002AIT02) took place. The study had the aim of
assessing the safety and tolerability of 0.5 mg ranibizumab
in wet AMD patients in eyes with visual acuity below 2/10
and/or fellow affected eye. The literal indications of this
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FIGURE 6. Example of statistical extraction.
interventional study were also coded in a specific page of
the I-maculaweb, so that it automatically notifies physicians
if a particular patient has the main inclusion criteria to be
eligible for the study. The system was also implemented with
the retreatment criteria based on visual acuity stability. There-
fore, once the patient was recruited, the system suggested if
treatment should be continued or discontinued according to
the protocol study.
Thanks to previous study results produced using the
described solution, the involved hospital has been selected
to participate in a randomized multicenter double-blind
phase III study of Lampalizumab, using I-maculaweb, to
evaluate its safety and efficacy in patients with geographic
atrophy secondary to AMD. This registrative study is impor-
tant for the commercialisation of Lampalizumab, the only
known drug to cure this type of AMD.
Another objective was to allow physicians to extract
data according to their needs, independently from technical
administration of the tool. We planned two different modal-
ities to extract records: one for the patient’s own center, in
which personal details are shown and the other, used for
statistical purposes, where all the center’s anonymized data
are visible. Physicians can enter specific extraction crite-
ria to obtain information by selecting which parameters are
required. Criteria can be set in order to select which parameter
values will be visible in the results table. Records can be
exploited with the possibility of defining particular thresh-
olds, both inclusive and exclusive, for numeric parameters.
For all other formats, there is the opportunity to indicate
specific requirements: for example positivity or negativity
for Boolean and equality or inequality to a certain value
for categorical parameters. All the criteria can be added,
modified or deleted as required. There is also the possibility
to save extractions and reuse thereafter. Queries are built
dynamically by interpreting the operators’ demands, and once
the extraction is completed, it is possible to view and save Z
score normalized data in an Excel format. In order to avoid
patients being individually recognizable, if the number of
patients involved in the results obtained is less than five,
the system will not show the search outcome. Fig. 6 shows
an example of statistical extraction that may be useful for
evaluating treatment efficacy in patients affected by selected
diagnosis.
V. DISCUSSION AND CONCLUSION
The application described in this paper fulfils the require-
ments specified by Chiang et al. [47] for Electronic Health
Record Systems in Ophthalmology.
The web-platform allows effective management, sharing
and reuse of information within primary care and clinical
research. The system results as highly user-friendly by oper-
ators and it can be effectively integrated into the physician
workflow.
Clear and precise clinical data will improve understanding
of real-lifemanagement of degenerative and vascular diseases
of the macula as well as increasing precise epidemiologic and
statistical data. Furthermore, this web-based application can
be easily employed as an electronic clinical research file in
clinical studies.
The achievement of this web tool attests that it can be con-
sidered a valuable tool for ophthalmology EHRs and clinical
studies as it overcomes the problems of other available EHR
systems.
It is planned, in the near future, to share the system with
other Italian hospitals not only for clinical research but also
for use in routine clinical practice. To encourage international
collaborations, the application will also be translated into a
multilingual website.
Specific aspects of the platform and implementation meth-
ods and techniques have already been presented to an
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international conference [48]. Moreover a journal paper
(entitled ‘‘Combining macula clinical signs and patient char-
acteristics for age-related macular degeneration diagnosis: a
machine learning approach’’) has been published by the BMC
Ophthalmology Journal [49]. This study exploited the high
data quality of stored information and the ease of extracting
data according to specific clinical criteria.
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